Literature DB >> 1851001

Biological activity and structural stability of N-deglycosylated recombinant human erythropoietin.

A J Sytkowski1, L Feldman, D J Zurbuch.   

Abstract

Controversy exists regarding the functional role of N-linked oligosaccharides in the hormone erythropoietin. We have now examined the role of carbohydrates in the hormone's action using quantitative enzymatic deglycosylation. N-deglycosylated hormone exhibited full biological activity and potency in vitro. Denaturing with 6M urea and renaturing revealed that both the native and N-deglycosylated forms recovered full activity as long as the intrachain disulfide bonds remained intact. Therefore, receptor recognition, subsequent biological activity and maintenance of tertiary structure are intrinsic properties of the polypeptide chain of erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851001     DOI: 10.1016/s0006-291x(05)80240-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?

Authors:  Liem Andhyk Halim; Vera Brinks; Wim Jiskoot; Stefan Romeijn; Kearkiat Praditpornsilpa; Anunchai Assawamakin; Huub Schellekens
Journal:  Pharm Res       Date:  2013-11-21       Impact factor: 4.200

2.  Erythropoietin processing in erythropoietic system and central nervous system.

Authors:  M Nagao; S Masuda; M Ueda; R Sasaki
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

Review 3.  Erythropoietin and cancer: the unintended consequences of anemia correction.

Authors:  Nataša Debeljak; Peter Solár; Arthur J Sytkowski
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

4.  Expression of functionally active sialylated human erythropoietin in plants.

Authors:  Jakub Jez; Alexandra Castilho; Josephine Grass; Karola Vorauer-Uhl; Thomas Sterovsky; Friedrich Altmann; Herta Steinkellner
Journal:  Biotechnol J       Date:  2013-03       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.